منابع مشابه
Neuropathic pain: emerging treatments.
Neuropathic pain remains one of the most challenging of all neurological diseases and presents a large unmet need for improved therapies. Many mechanistic details are still lacking, but greater knowledge of overlapping mechanisms and disease comorbidities has highlighted key areas for intervention. These include peripheral and central hyperexcitability. Among the molecular drivers are ion chann...
متن کاملEmerging treatments for PTSD.
Recent innovations in posttraumatic stress disorder (PTSD) research have identified new treatments with significant potential, as well as novel enhancements to empirically-validated treatments. This paper reviews emerging psychotherapeutic and pharmacologic interventions for the treatment of PTSD. It examines the evidence for a range of interventions, from social and family-based treatments to ...
متن کاملDementia: new theories, new treatments.
Approximately 4 million people in the United States suffer from Alzheimer’s disease—an irreversible, progressive, neurodegenerative disorder. Ten percent of people over age 65 and half of people over age 85 are affected by the disease. The estimated annual cost of caring for a patient with advanced Alzheimer’s disease is more than $50,000. Given that Alzheimer’s is expected to become a much mor...
متن کاملEmerging treatments for essential thrombocythemia
In 1934, Epstein and Goedel used the term hemorrhagic thrombocythemia to describe a disorder characterized by permanent elevation of a platelet count to more than three times normal, hyperplasia of megakaryocytes, and the tendency for venous thrombosis and spontaneous hemorrhage. Over the last 75 years, and particularly in the past 6 years, major progress has been made in our understanding of e...
متن کاملEmerging Treatments for Rheumatoid Arthritis:
Early treatment with disease-modifying anti-rheumatic drugs (DMARDs)--alone or in combination-can prevent joint damage and minimize disability. Until recently, the DMARDs used predominantly in patients with rheumatoid arthritis had been methotrexate, sulfasalazine, and hydoxychloroquine. Older DMARDs such as gold, d-penicillamine, and azathioprine have fallen out of favor because of their longt...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of College of Medical Sciences-Nepal
سال: 2012
ISSN: 2091-0673,2091-0657
DOI: 10.3126/jcmsn.v7i3.6712